<DOC>
	<DOCNO>NCT00004374</DOCNO>
	<brief_summary>OBJECTIVES : I. Analyze prospectively course amyloid deposition patient primary , secondary , myeloma-associated , hereditary amyloidosis . II . Determine abnormalities humoral delayed-type hypersensitivity patient . III . Identify prognostic factor hereditary amyloidosis develop test genetic defect associate systemic amyloidosis . IV . Diagnose familial amyloidotic polyneuropathy ( FAP ) prior symptom onset . V. Validate correlation low serum prealbumin retinol bind protein level amyloidosis patient FAP .</brief_summary>
	<brief_title>Study Systemic Amyloidosis Presentation Prognosis</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Patients receive comprehensive evaluation emphasis identify prognostic diagnostic factor . Assessments include gastrointestinal , renal , hematologic , dermatologic , cardiac , serologic study . Immunologic study include antinuclear antibody , latex fixation , serum urine electrophoresis . Genetic tree construct use detailed family history data ; blood urine sample routinely collect relative . Family member patient familial amyloidotic polyneuropathy type II ( Indiana type ) undergo flexor retinaculum biopsy wrist .</detailed_description>
	<mesh_term>Amyloidosis</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Systemic amyloidosis , i.e . : Primary , myeloma associate Secondary , e.g. , associate follow condition : Rheumatoid arthritis Inflammatory bowel disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>amyloidosis</keyword>
	<keyword>arthritis &amp; connective tissue disease</keyword>
	<keyword>genetic disease dysmorphic syndrome</keyword>
	<keyword>rare disease</keyword>
</DOC>